Enveric BiosciencesENVB
13F holders, Q4 2024 (December 31)19holders +2
2new positions
1sold out
1famous investor
$0.36avg. 13F price*
At the end of Q4 2024, 19 institutions reported holding Enveric Biosciences Inc. (ENVB) in their 13F filings, up 2 from Q3 2024. 2 opened new positions and 1 sold out. The largest holders were AdvisorShares Investments LLC ($215K), Geode Capital Management, LLC ($78K) and UBS Group AG ($28K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Enveric Biosciences Inc.
- CUSIP
- 29405E208
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $12K |
| Exits | 1 | $271 |
All 13F filers, Q3 2024 → Q4 2024: 379,463 shares bought and 11,677 shares sold, net +367,786 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| AdvisorShares Investments LLC | 0.04% | Add +63.4% | 599,854 | $215K |
| Geode Capital Management, LLC | 0.00% | Reduce -0.6% | 216,594 | $78K |
| UBS Group AG | 0.00% | Add +10626.1% | 78,408 | $28K |
| Virtu Financial LLC | 0.00% | Add +141.2% | 55,763 | $20K |
| Two Sigma Securities, LLC | 0.00% | Add +4.0% | 31,872 | $11K |
| XTX Topco Ltd | 0.00% | New | 22,007 | $8K |
| Vanguard Group Inc. | 0.00% | No change | 18,198 | $7K |
| Citadel Advisors | 0.00% | Add +17.8% | 15,017 | $5K |
| Two Sigma Investments, LP | 0.00% | Reduce -9.3% | 12,145 | $4K |
| Jane Street Group, LLC | 0.00% | New | 10,815 | $4K |
| BlackRock, Inc. | 0.00% | No change | 9,010 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -49.3% | 8,810 | $3K |
| Group One Trading LLC | 0.00% | No change | 273 | $98 |
| Bank of America Corp. | 0.00% | Add +4.0% | 180 | $65 |
| National Bank of Canada | 0.00% | Reduce -1.4% | 70 | $25 |
| Avior Wealth Management, LLC | 0.00% | No change | 50 | $17 |
| SBI Securities Co., Ltd. | 0.00% | — | 19 | $7 |
| Wells Fargo & Company | 0.00% | No change | 16 | $6 |
| Hantz Financial Services, Inc. | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is ENVB's weight in each manager's 13F, not the share of Enveric Biosciences Inc. the manager owns.